KRM Ayurveda share price
NSE: KRMAYURVEDPharmaceuticals & Biotechnology
Last close ₹238.80up ₹5.75 (2.47%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹233.05.
Range of traded prices from listing on 29 Jan 2026 to 23 Oct 2026
₹156.15Low, 4 Feb 2026₹343.95High, 10 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹508 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 1 May 2026
- 4.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Jan 2026
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 1 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 61,00060.7% delivered
Results
Standalone; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026Filed 10 Aug
- Revenue
- ₹32 Cr
- Net profit
- ₹9.08 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 28.1%
Revenue by year
Net profit by year, a loss in red
| ₹ crore | Jun 2026Filed 10 Aug |
|---|---|
| Revenue | 32.3 |
| Net profit | 9.1 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 28.1% |
Standalone. The quarter to Jun 2026, the first on record.
Business segments
In the quarter to Jun 2026 the company reports one business segment which carries all its revenue.
Peers and competitors
Pharmaceuticals, 216 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to KRM Ayurveda in market cap.
KRM Ayurveda is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Amanta HealthcareAMANTA | 633 | 43.1 | 2.9 | 13.0 | – | – | 6.7% | 9.0% | 0.00% |
 WanburyWANBURY | 624 | 11.2 | 4.3 | 8.4 | +3.6% | +30.0% | 54.9% | 23.3% | 0.00% |
 Influx HealthtechINFLUX | 595 | 28.9 | 5.9 | – | – | – | 20.4% | – | 0.00% |
 TranschemTRANSCHEM | 513 | 76.2 | 6.1 | – | −100.0% | +47.5% | 8.3% | −4.9% | 0.00% |
 Trident LifelineTLL | 488 | 23.2 | 4.9 | – | – | – | 25.5% | – | 0.00% |
 Haleos LabsHALEOSLABS | 453 | 28.7 | 2.1 | 13.7 | −3.1% | −8.5% | 7.7% | 7.4% | 0.10% |
 Infinium PharmachemINFINIUM | 446 | 36.7 | 3.7 | – | +21.8% | +41.8% | 10.5% | – | 0.00% |
 Albert DavidALBERTDAVD | 436 | 19.3 | 1.1 | 16.1 | +11.4% | +258.5% | 5.8% | 4.1% | 0.65% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
Sep 2026
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 232.20 | 243.50 | 224.00 | 238.80 | 232.92 | 61,000 | 60.7% |
| 22 Oct 2026 | 235.00 | 235.00 | 230.00 | 233.05 | 233.01 | 20,000 | 85.0% |
| 21 Oct 2026 | 244.00 | 245.00 | 221.35 | 237.90 | 236.87 | 2,03,000 | 72.4% |
| 19 Oct 2026 | 262.00 | 262.00 | 244.00 | 246.60 | 249.60 | 1,17,000 | 69.2% |
| 16 Oct 2026 | 263.25 | 264.15 | 261.00 | 261.45 | 262.75 | 16,000 | 87.5% |
| 15 Oct 2026 | 270.80 | 274.95 | 264.15 | 265.50 | 267.80 | 35,000 | 82.9% |
| 14 Oct 2026 | 271.00 | 274.00 | 266.05 | 269.50 | 268.64 | 28,000 | 67.9% |
| 13 Oct 2026 | 266.00 | 272.95 | 263.00 | 270.20 | 267.56 | 1,64,000 | 87.8% |
| 12 Oct 2026 | 273.00 | 273.05 | 264.00 | 265.55 | 268.30 | 43,000 | 67.4% |
| 9 Oct 2026 | 271.10 | 278.00 | 271.00 | 273.05 | 273.73 | 71,000 | 49.3% |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- KRM Ayurveda Limited
- NSE symbol
- KRMAYURVED
- ISIN
- INE1MTV01019
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Jan 2026
- Face value
- ₹10